Crossmark

Alpha-asarone relieves nasal inflammation, epithelial barrier damage, and mitochondrial damage in allergic rhinitis by inhibiting mitochondrial ROS via the SIRT1/PGC-1α pathway

Crossref DOI link: https://doi.org/10.1007/s00210-025-04338-x

Published Online: 2025-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Bin

Gao, Weimin

Li, Haitong

Cao, Xiaojuan

Chen, Xiaohong

Dong, Nannan

Wu, Lingfang

Luo, Yunzhen
Funding

Funding for this research was provided by:

This work was financially supported by the Zhejiang Provincial Medicine and Health Technology Project (2022KY1247, 2022KY1247, 2022KY1247, 2022KY1247, 2022KY1247, 2022KY1247, 2022KY1247, 2022KY1247)
License Information

Text and Data Mining valid from 2025-06-14

Version of Record valid from 2025-06-14
More Information

Article History

Received: 13 March 2025

Accepted: 26 May 2025

First Online: 14 June 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below